ALT L-R: Associate Professors Sylvia Alonso (NUS) and Mireille Lahoud (Monash BDI), senior authors on the Molecular Therapy paper, Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice.
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity.
A fantastic collaboration between @MonashBDI and @NUSingapore.
doi.org/10.1016/j.ymthe.2024…
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity.
A fantastic collaboration between @MonashBDI and @NUSingapore.
doi.org/10.1016/j.ymthe.2024…
📢Don't miss our BDI seminar this Fri 17 May, 12-1pm!
𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso @SAlonsoGroup@nusingapore
𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases
bit.ly/3uCUMgc
ALT 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso @SAlonsoGroup @nusingapore
𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases
𝗪𝗵𝗲𝗻: Fri 17 May 12-1pm
Featuring our new publication on @MolTherapy deeply characterizing a cDC1 targeting vaxx strategy we have focused on for years, this time in SARS-CoV-2 context. Overall, our findings present its promise as a next gen pandemic response vaxx strategy Congrats to @_immunogeNIC agn!
Proudly sharing that the 1st phase of my PhD work is officially published! Here, we characterized the immune response elicited by a Clec9A-cDC1 targeting SARS-CoV-2 vaccine. Thankful for @NUSMedAlonsoS guidance and all coauthors' contributions! See below our summarized findings.
Had an engaging week at the #IVBDC2023: Shared our work on mosquito reproduction & population genomics; Was inspired by cool science & emerging technology in vector control; Had fun catching up with ex-students! Big 🙏🏾 to @SAlonsoGroup & @NUS_DBS
Featuring the boss @NUSMedAlonsoS presenting a translational and exciting story about the lab's cDC1 targeting vaccine research at the annual SgSI symposium. 🎉🎉🎉